G. Schmidt

发表

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters

Z. Szallasi, M. Gerlinger, N. McGranahan, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

iDermatoPath – a novel software tool for mitosis detection in H&E‐stained tissue sections of malignant melanoma

A. Schäpe, J. Ring, N. Harder, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy

K. Steele, M. Rebelatto, T. Wiestler, 2019, Journal of Immunotherapy for Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients

J. Barrett, S. Sridhar, H. Sade, 2021 .

583 Quantitative computational assessment of PD-L1 enables robust patient selection for biomarker-informed anti-PD-L1 treatment of NSCLC patients

H. Sade, P. Sontakke, Anatoliy Shumilov, 2022, Regular and Young Investigator Award Abstracts.

579 Novel digital image approach of multiplex immunofluorescence based PD-L1 expression enables the stratification of advanced NSCLC patients treated with durvalumab

A. Gupta, I. Achour, F. Segerer, 2022, Regular and Young Investigator Award Abstracts.

365 Computational pathology delivers objective and quantitative PD-L1 expression analysis for enrichment of responders to durvalumab in non-small cell lung cancer (NSCLC)

Lina Meinecke, Anatoliy Shumilov, T. Padel, 2021, Journal for ImmunoTherapy of Cancer.

Abstract 468: Quantitative assessment of IHC using computational pathology allows superior patient selection for biomarker-informed patients

H. Sade, Lina Meinecke, Anatoliy Shumilov, 2022, Cancer Research.

DASGAN - Joint Domain Adaptation and Segmentation for the Analysis of Epithelial Regions in Histopathology PD-L1 Images pdf

Nicolas Brieu, Ansh Kapil, Keith Steele, 2019, ArXiv.

Domain Adaptation-based Augmentation for Weakly Supervised Nuclei Detection pdf

Nicolas Brieu, Armin Meier, Guenter Schmidt, 2019, ArXiv.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.